EC Number   |
Inhibitors |
Structure |
|---|
    1.14.15.4 | (1R)-2-[2-[(1S)-1-(4-chlorophenyl)ethyl]-3,3-dioxido-1,2-dihydroimidazo[5,1-d][1,2,5]thiadiazin-4-yl]-1-phenylethanol |
- |
   |
| 1.14.15.4 | (1S)-2-[2-[(1S)-1-(4-chlorophenyl)ethyl]-3,3-dioxido-1,2-dihydroimidazo[5,1-d][1,2,5]thiadiazin-4-yl]-1-phenylethanol |
- |
|
| 1.14.15.4 | (5Z)-5-(1H-imidazol-5-ylmethylene)-5,6,7,8-tetrahydronaphthalene-2-carbonitrile |
50% inhibition at 0.0069 mM, selective for CYP11B1 |
|
| 1.14.15.4 | (R)-4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile |
FAD286; FAD286, CYP11B2 inhibitor, inhibited CYP11B2 and CYP11B1 activities |
|
| 1.14.15.4 | 1-(1H-inden-2-yl)-1H-imidazole |
CYP11B2 IC50: 448 nM, no inhibition of CYP11B1, recombinant enzymes |
|
| 1.14.15.4 | 1-(3,4-dihydronaphthalen-2-yl)-1H-imidazole |
CYP11B1 IC50: 639 nM, CYP11B2 IC50: 334 nM, recombinant enzymes |
|
| 1.14.15.4 | 1-(3-bromobenzyl)-1H-imidazole |
- |
|
| 1.14.15.4 | 1-(3-chlorobenzyl)-1H-imidazole |
- |
|
| 1.14.15.4 | 1-(3-cyanobenzyl)-1H-imidazole |
- |
|
| 1.14.15.4 | 1-(3-fluorobenzyl)-1H-imidazole |
- |
|
